Adagene Inc. (ADAG)
NASDAQ: ADAG · Real-Time Price · USD
2.440
+0.030 (1.24%)
At close: Oct 22, 2026, 4:00 PM EDT
2.440
0.00 (0.00%)
After-hours: Oct 22, 2026, 4:25 PM EDT
Adagene Market Cap
Adagene has a market cap or net worth of $163.83 million as of October 22, 2026. It is the 22,026th most valuable company in the world and the 3,736th biggest in the United States. Its market cap has increased by 83.92% in one year.
Market Cap
163.83M
Enterprise Value
42.01M
1-Year Change
83.92%
Global Rank
Country Rank
#3,736 United States
Category
ChartMarket Cap Chart
Since the IPO on February 9, 2021, Adagene's market cap has decreased from $804.22M to $163.83M, a decrease of -79.63%. That is a compound annual growth rate of -24.35%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2026 | 163.83M | 83.92% |
| Dec 31, 2025 | 89.08M | 1.11% |
| Dec 31, 2024 | 88.10M | 4.06% |
| Dec 29, 2023 | 84.66M | 47.15% |
| Dec 30, 2022 | 57.54M | -83.64% |
| Dec 31, 2021 | 351.59M | -56.28% |
| Feb 9, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Eledon Pharmaceuticals | 183.42M |
| Whitehawk Therapeutics | 181.86M |
| Precision BioSciences | 181.07M |
| Entrada Therapeutics | 179.92M |
| Oramed Pharmaceuticals | 172.63M |
| ALX Oncology Holdings | 171.46M |
| NervGen Pharma | 165.58M |
| NovaBridge Biosciences | 165.30M |